EXACERBATION ASSESSMENT FORM

Similar documents
EXACERBATION ASSESSMENT FORM

COPD Treatable. Preventable.

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

an inflammation of the bronchial tubes

Management of Acute Exacerbations

Guideline for the Diagnosis and Management of COPD

Management of Acute Exacerbations of COPD

Clinical Implications of Asthma Phenotypes. Michael Schatz, MD, MS Department of Allergy

Presented by UIC College of Nursing

Chronic Obstructive Pulmonary Disease 1/18/2018

Chronic Obstructive Pulmonary Disease (COPD) Clinical Guideline

ASTHMA. Epidemiology. Pathophysiology. Diagnosis. IAP UG Teaching slides

COPD exacerbation. Dr. med. Frank Rassouli

COPD is a syndrome of chronic limitation in expiratory airflow encompassing emphysema or chronic bronchitis.

JOINT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MANAGEMENT GUIDELINES

Cough Associated with Bronchitis

2/4/2019. GOLD Objectives. GOLD 2019 Report: Chapters

Provider Respiratory Inservice

How can I benefit most from my COPD medications?

In 2002, it was reported that 72 of 1000

your breathing problems worsen quickly. you use your rescue inhaler, but it does not relieve your breathing problems.

1 I *********IF YOU ARE NOT ON ALLERGY SHOTS PLEASE SKIP THIS SECTION AND MOVE TO PAGE 2********* NAME: AGE: ---- ID (For Office Use Only):

Integrated Cardiopulmonary Pharmacology Third Edition

GINA. At-A-Glance Asthma Management Reference. for adults, adolescents and children 6 11 years. Updated 2017

Self-management plan for COPD

PANEL KEGAWAT DARURATAN SISTEM PERNAPASAN (SERANGAN ASMA AKUT, PNEUMONIA DAN COPD) dan EDEMA PARU

Respiratory Diseases and Disorders

Exacerbations of COPD. Dr J Cullen

RESPIRATORY CARE IN GENERAL PRACTICE

2/12/2015. ASTHMA & COPD The Yin &Yang. Asthma General Information. Asthma General Information

Epiglottitis. Bronchitis. Bronchiolitis. Pneumonia. Croup syndrome. Miss. kamlah 2

Problem Based Learning Session. Mr Robinson is a 67 year old man. He visits the GP as he has had a cough and fever for 5 days.

Acute Respiratory Infection. Dr Anthony Gibson

Differential diagnosis

Unconscious exchange of air between lungs and the external environment Breathing

Question by Question (QXQ) Instructions for the Pulmonary Diagnosis Form (PLD)

COPD. Breathing Made Easier

Global Strategy for the Diagnosis, Management and Prevention of COPD 2016 Clinical Practice Guideline. MedStar Health

COPD. The goals of COPD. about. you quit. If you. efforts to quit. Heart

ASTHMA-COPD OVERLAP SYNDROME 2018: What s All the Fuss?

Turning Science into Real Life Roflumilast in Clinical Practice. Roland Buhl Pulmonary Department Mainz University Hospital

Bronchitis. Anatomy of the Lungs The lungs allow us to fill our blood with oxygen. The oxygen we breathe is absorbed into our blood in the lungs.

Reference Guide for Group Education

COPD/Asthma. Prudence Twigg, AGNP

Decramer 2014 a &b [21]

CHF for Clinician. AtHomeCare.com

Lead team presentation: Roflumilast for treating chronic obstructive pulmonary disease [ID984]

Chronic Obstructive Pulmonary Disease

MEDICAL ASSISTANCE BULLETIN

COPD: From Hospital to Home October 5, 2015 Derek Linderman, MD Associate Professor COPD Center Pulmonary Nodule Clinic

HOSPITAL RECORD ABSTRACTION FORM

Basic mechanisms disturbing lung function and gas exchange

Respiratory System. Respiratory System Overview. Component 3/Unit 11. Health IT Workforce Curriculum Version 2.0/Spring 2011

Function of the Respiratory System. Exchange CO2 (on expiration) for O2 (on inspiration)

Pulmonary Pearls. Medical Pearls. Case 1: Case 1 (cont.): Case 1: What is the Most Likely Diagnosis? Case 1 (cont.):

Chronic obstructive pulmonary disease

USAID Health Care Improvement Project. pneumonia) respiratory infections through improved case management (amb/hosp)

Florida Hospital Spine Center Patient Intake Form

Supplementary Appendix

PATHOLOGY & PATHOPHYSIOLOGY

Advances in the management of chronic obstructive lung diseases (COPD) David CL Lam Department of Medicine University of Hong Kong October, 2015

CARE OF THE ADULT COPD PATIENT

COPD Management in LTC: Presented By: Jessica Denney RRT

Public Dissemination

Management of Common Respiratory Disorders in Children. Whitney Pressler, MD Pediatric Brown Bag Series Webinar June 14, 2016

Management of Common Respiratory Disorders in Children. Disclosures. Roadmap 6/10/2016

Paramedic Rounds. Pre-Hospital Continuous Positive Airway Pressure (CPAP)

Disclosure and Conflict of Interest 8/15/2017. Pharmacist Objectives. At the conclusion of this program, the pharmacist will be able to:

HEALTH SERVICES POLICY & PROCEDURE MANUAL

SABA: VENTOLIN EVOHALER (SALBUTAMOL) SAMA: ATROVENT IPRATROPIUM. Offer LAMA (discontinue SAMA) OR LABA

CLINICAL PATHWAY. Acute Medicine. Chronic Obstructive Pulmonary Disease

Peak Expiratory Flow Rate (PEFR) for ED Management of Acute Asthma Exacerbation

Some Facts About Asthma

National Asthma Educator Certification Board Detailed Content Outline

Chronic obstructive pulmonary disease

PATIENT INFORMATION. ADVAIR DISKUS [AD vair DISK us] (fluticasone propionate and salmeterol inhalation powder) for oral inhalation

MCKAY UROLOGY LINCOLNTON OFFICE PATIENT HISTORY FORM

Pulmonary Pathway & Assessment/Plan of Care: Acute. Pulmonary Risk Factors & Pulmonary History

Reducing unnecessary antibiotic use in respiratory tract infections in children

Living well with COPD

PATIENT INFORMATION BREO ELLIPTA

Chronic Obstructive Pulmonary Disease (COPD) KAREN ALLEN MD PULMONARY & CRITICAL CARE MEDICINE VA HOSPITAL OKC / OUHSC

Chapter 22. Pulmonary Infections

Medical History. Participant Id#: Acrostic: Tech ID#: Date: / / 1 How would you say your health currently compares with other persons of your age?

REFERRAL GUIDELINES RESPIRATORY

HQO s Episode of Care for Chronic Obstructive Pulmonary Disease

THE CHALLENGES OF COPD MANAGEMENT IN PRIMARY CARE An Expert Roundtable

A patient educational resource provided by Boehringer Ingelheim Pharmaceuticals, Inc.

Chapter 10 Respiratory System J00-J99. Presented by: Jesicca Andrews

PATIENT INFORMATION Chronic Obstructive Pulmonary Disease (COPD) Fact Sheet

Asthma Tutorial. Trainer MRW. Consider the two scenarios, make an attempt at the questions, what guidance have you used?

COPD UPDATE ıdr Shitrit David ıhead of the Pulmonary Department ımeir Medical Center

The Respiratory System

COUNTY OF MORRIS DEPARTMENT OF LAW & PUBLIC SAFETY OFFICE OF HEALTH MANAGEMENT

Influenza. What Is Influenza?

Upper Respiratory Tract Infections

Avian Influenza Clinical Picture, Risk profile & Treatment

Cardiovascular and Respiratory Disorders

Objectives. Case Presentation. Respiratory Emergencies

Transcription:

EXACERBATION ASSESSMENT FORM ID NUMBER: 0a) Form Completion Date... 0b) Staff Code... Administrative Information 1) Date of clinic visit: 2) What type of Event is this?... Participant/HCU-triggered... 1 Symptom/EXACT-Triggered... 2 Examination (completed by Coordinator): 3) Temperature. C 4) Weight. kg 5) Pulse min -1 6) Sp02 % 7) tes: Participant Interview (completed by Coordinator): 8) Have you had any changes to your respiratory medications related to this event (this includes new prescriptions or self-medication)?... Yes... 1... 0 Go to 12 Exacerbation Assessment Form - EAF Page 1 of 5

Please specify type of medication for this event by checking the appropriate box: 9) MEDICATION Date Prescribed a1) Antibiotic 1: a2) Antibiotic 2: b1) Inhaled corticosteroids: c1) Inhaled corticosteroids w/long-acting ß 2 -agonists: d1) Aminophyllines: e1) ß 2 -agonists Short-Acting: f1) ß 2 -agonists Long-Acting: g1) Short-acting anticholinergic h1) Long-acting anticholinergic i1)short-acting ß 2 - agonists/anticholinergic: j1) Long-acting ß 2 - agonists/anticholinergic: k1) Roflumilast (Daxas, Daliresp) (Y/N): l1) Leukotriene antagonists: m1) Other Medications: 10) TREATMENTS Date Prescribed a) Pulmonary Rehabilitation (Y/N): b) Supplemental Oxygen (Y/N): c) Other Clinical Treatments: Duration (Days) Duration (Days) 11) Have you had a new or changed prescription for oral steroids as a result of the change in your respiratory symptoms? 11a) What type of oral steroids were prescribed? 11a1) Specify: 11b) What date were the oral steroids prescribed? 11c) What is the duration of this prescription? days 11d) What was the total dosage of oral steroids prescribed? mg Exacerbation Assessment Form - EAF Page 2 of 5

12) Have you taken any pain medications such as aspirin, Advil, Aleve, or Tylenol? 12a) Pain medicine 1: 12a1) Specify: 12b) Pain medicine 2: 12b1) Specify: 12c) Pain medicine 3: 12c1) Specify: 12d) Pain medicine 4: 12d1) Specify: Review of Symptoms (Completed by Coordinator) 13) How serious is this flare-up/exacerbation compared to previous flare ups/exacerbations? More serious... 1 As serious... 2 Less serious... 3 Never had an exacerbation before... 4 Exacerbation Assessment Form - EAF Page 3 of 5

14) Since the start or worsening of your symptoms, have you experienced any of the following for at least 2 or more consecutive days? Yes a) Increase or Worsening in Shortness of Breath (Dyspnea)... b) Change in sputum color (purulence)... c) Increase in sputum volume... 15) Since the start or worsening of your symptoms, have you experienced any of the following for at least 2 or more consecutive days? Yes a) Runny se/nasal discharge... b) Increase or worsening of Wheeze... c) Sore throat... d) Increase or worsening of Cough... e) Fever... 16) Have you had any OTHER new Symptoms related to this event?... Yes... 1... 0 a) Symptom 1: b) Symptom 2: c) Symptom 3: d) Symptom 4: e) Symptom 5: f) Symptom 6: g) Symptom 7: h) Symptom 8: i) Symptom 9: j) Symptom 10: Exacerbation Assessment Form - EAF Page 4 of 5

Physician Assessment 17) Wheezes: Yes 18) Crackles: Yes 19) Gallop: Yes 20) Edema: Yes 21) Were other conditions present at the time of this event? (Y/N) If no skip to 23 22) If yes, please specify the conditions present: a) Pneumonia: Yes Go to 22c d) Other: Yes Specify: b) Pneumonia confirmed by: Chest film Clinical examination Both e) Other: Yes Specify: c) Congestive Heart Failure: Yes f) Other: Yes Specify: 23) Diagnosis of a COPD exacerbation: Yes Skip to Q30 26) Potential Etiology: Infectious (answer Q27) Weather Treatment n- Compliance Air pollution Unknown 24) Exacerbation severity: Mild Moderate Severe Very Severe 28) Potential Infectious Etiology: Viral Bacterial Unknown Other (specify): 25) Duration to date: Less than 1 Day 1-2 Days 3-5 Days 1 Week More than 1 Week Unknown 29) Participant to proceed with exacerbation visit? Yes END t COPD exacerbation Outside of visit window (> 72 hrs) Other Specify: END (Do not proceed to Q30 or 31) 30) If not a COPD exacerbation, what: Lack of symptomatic criteria Upper respiratory tract infection Change in comorbid condition Go to Q28 Other Specify: 31) Change(s) in what comorbid condition (s)? Cardiovascular (Angina, CHF, etc) Neurological Other Specify: Exacerbation Assessment Form - EAF Page 5 of 5